Skip to content
Recall Observatory FDA recall evidence

Drug product

Mercaptopurine Tablets, USP 50 mg, packaged in: a) 25-count bottle (NDC 69076-913-02), b) 250-count bottle (NDC 69076-913-25), Rx only, Manufactured for: Quinn Pharmaceuticals, Boca Raton, FL, www.quinnrx.com

D-0367-2024

February 09, 2024

Class III

Product summary

Firm
Stason Pharmaceuticals, Inc.
Event
Event 93960
Status
Terminated
Classification
Class III
Quantity
54, 131 bottles
Official record key
drug-enforcement:D-0367-2024

Official wording

Reason: Failed Dissolution Specifications: results slightly under spec at at 9-months.

Code information: Lot #: a)22K012, 22K013A, Exp: 04/30/2024; 23A001, 23A002A, Exp: 07/31/2024; 23D006, 23D007A, 23D007C, Exp:10/31/2024; b)22K013B, Exp: 04/30/2024; 23A002B, Exp:07/31/2024; 23D007B, Exp: 10/31/2024.

Distribution pattern: USA Nationwide

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Dissolution Specifications